Takeda executive reports 84,787 ADS holdings
Takeda Pharmaceutical executive Ibrahim Ramy Riad Ahmed filed an initial statement of ownership, reporting 84,787 American Depositary Shares of the company.
Rhea-AI Filing Summary
Takeda Pharmaceutical executive Ibrahim Ramy Riad Ahmed filed an initial statement of ownership, reporting 84,787 American Depositary Shares of the company. This total includes 48,928 restricted stock units (RSUs), each convertible into one ADS. The RSUs vest in stages on July 1, 2026 (24,022 shares), July 1, 2027 (16,554 shares) and July 1, 2028 (8,352 shares), showing a multi‑year equity-based compensation structure tied to his role as President of the PDT business unit.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | American Depositary Shares | -- | -- | -- |
Footnotes (1)
- F1. Includes 48,928 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (24,022 shares), July 1, 2027 (16,554 shares) and July 1, 2028 (8,352 shares).
Key Figures
Key Terms
restricted stock units financial
RSUs financial
beneficial ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Ibrahim Ramy Riad Ahmed report owning in Takeda (TAK) on this Form 3?
How many Takeda (TAK) restricted stock units does Ahmed hold and what do they represent?
What is the vesting schedule for Ahmed’s Takeda (TAK) restricted stock units?
Is this Takeda (TAK) Form 3 a report of a new insider trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.